Vaccination

Rich countries getting new COVID vaccine before poorer ones

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign ...

Medical economics

Study calls for fractional doses of COVID-19 vaccines

To stretch the supply and accelerate global vaccination against the coronavirus, a team of economists is calling for the testing of fractional doses of COVID-19 vaccines. Their findings are published in the Proceedings of ...

Vaccination

Covax opens new front in pandemic arms race

Covax aims to break the COVID-19 pandemic in 2022 by ensuring a steady supply of vaccines at last for the world's poorest countries—and swiftly getting them into arms.

Medical economics

What the COVID-19 pandemic has taught us about flu vaccines

A recent report from the National Academies of Science, Engineering and Medicine (NASEM) finds that much needs to be done if we want to be prepared to respond to a potential influenza pandemic, particularly when it comes ...

Vaccination

Novavax asks EU drug regulator to OK its COVID vaccine

The European Union's drug regulator said it received an application from Novavax to authorize the American biotechnology company's coronavirus vaccine, a request that could significantly boost the continent's vaccine supplies ...

Vaccination

Brazil turns the tide with Covid-19 vaccines

Despite a slow start plagued by much controversy that still haunts President Jair Bolsonaro, Brazil's coronavirus vaccination campaign is now one of the fastest-paced and farthest-reaching in the world.

page 1 from 10